Cardiol Therapeutics Inc. CRDL, a clinical-stage life sciences company, reported results from its Phase II open-label MAvERIC ...

(TSX: CRDL) has seen success under a phase II trial conducted on CardiolRx, which is the company’s lead small molecule drug ...

Look at Cardiol Therapeutics, for example. At the moment, the company is developing novel therapeutic approaches for patients ...

Heart inflammation is a serious condition that requires timely medical intervention. Understanding its causes and symptoms ...

It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an ...